Gelteq Limited - Ordinary Shares (GELS)

0.7600
+0.0200 (2.70%)
NASDAQ · Last Trade: Mar 22nd, 3:55 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors

Detailed Quote

Previous Close0.7400
Open0.7200
Bid0.6700
Ask0.7500
Day's Range0.6800 - 0.7600
52 Week Range0.6401 - 4.110
Volume10,450
Market Cap-
PE Ratio (TTM)-
EPS (TTM)-
Dividend & YieldN/A (N/A)
1 Month Average Volume14,036

Chart

About Gelteq Limited - Ordinary Shares (GELS)

Gelteq Limited is a biotechnology company focused on the development and commercialization of innovative drug delivery systems and therapeutic solutions. The company specializes in utilizing advanced technologies to formulate and manufacture complex pharmaceuticals, aiming to enhance the efficacy and safety of treatments. Gelteq's research initiatives are dedicated to addressing unmet medical needs across various therapeutic areas, and the company collaborates with healthcare professionals and institutions to bring its cutting-edge products to market. Through its commitment to scientific excellence and patient-centered solutions, Gelteq strives to improve patient outcomes and transform healthcare delivery. Read More

News & Press Releases

Investor Summit Announces Q1 Presenter Line Up (Presentations 3/25, 1-on-1s 3/26)
NEW YORK, NY / ACCESS Newswire / March 20, 2026 / The Investor Summit today announced the lineup of public companies scheduled to present at its upcoming Virtual March 25-26, 2026 event.
Via ACCESS Newswire · March 20, 2026
Trump: Netflix-Paramount Skydance-Warner Bros. Deal? Watch TOON, SEGG, ASST, GELS Small-Cap Stocks
Kartoon Studios (NYSE: TOON) is drawing heightened investor attention as political uncertainty clouds one of the media industry’s most closely watched potential mergers. President Donald Trump has publicly opposed Netflix (NASDAQ: NFLX) ’s proposed acquisition of Warner Bros. Discovery (NASDAQ: WBD), raising the possibility that his administration could seek to delay or block the transaction. While courts could ultimately overrule such action, the near-term impact would likely be prolonged uncertainty—forcing streaming platforms and content owners to reassess their growth and acquisition strategies.
Via AB Newswire · January 14, 2026
Top stock movements in today's session.chartmill.com
Via Chartmill · January 14, 2026
Gelteq Announces Commencement of Preclinical Trial Targeting Oil Soluble Drug Market with Novel Delivery Platformstocktwits.com
Via Stocktwits · October 29, 2025
Gelteq Announces New Product Development Agreement with Melbourne Health for Novel Bowel Polyp Growth Reduction Compoundstocktwits.com
Via Stocktwits · October 29, 2025
Gelteq Technology Powers U.S. Product Launches of its Nutraceutical Products for Partnerstocktwits.com
Via Stocktwits · September 12, 2025
Gelteq Announces Commencement of Preclinical Trial for Novel Gel-Based Antihistamine Formulation Targeting Allergy Marketstocktwits.com
Via Stocktwits · September 8, 2025
The trading volume of these stocks is deviating from the norm in today's session.chartmill.com
Via Chartmill · January 14, 2026
Top movers analysis in the middle of the day on 2026-01-14: top gainers and losers in today's session.chartmill.com
Via Chartmill · January 14, 2026
Traders are paying attention to the gapping stocks in Wednesday's session.chartmill.com
Via Chartmill · January 14, 2026
Stay updated with the stocks that are on the move in today's pre-market session.chartmill.com
Via Chartmill · January 14, 2026
These stocks are moving in today's after hours sessionchartmill.com
Via Chartmill · January 13, 2026
Gelteq Signs Three Year Sales Agreement with Shenzhen Mana Health Management Co. Strengthening Gelteq’s Nutritional Product Expansion into Chinastocktwits.com
Gelteq signed a three-year agreement with Shenzhen Mana Health Management to distribute its sugar-lowering nutritional products in China, guaranteeing approximately $1.3 million in minimum revenue.
Via Stocktwits · December 11, 2025
Gelteq Preclinical Study Demonstrates Enhanced Oral Delivery of Oil-Soluble and Poorly Soluble Drugs Using Its Gel-Based Platformstocktwits.com
Gelteq announced preclinical results demonstrating its proprietary gel platform significantly improved the absorption and bioavailability of poorly soluble drugs.
Via Stocktwits · December 9, 2025
Gelteq to Present at Investor Summit Virtual on December 9, 2025stocktwits.com
Gelteq Limited CEO, Nathan Givoni, is scheduled to present updates on the company's growth strategy and market positioning at the Q4 Investor Summit Virtual on December 9, 2025.
Via Stocktwits · December 9, 2025
Get insights into the top gainers and losers of Tuesday's after-hours session.chartmill.com
After the closing bell on Tuesday, let's take a glimpse of the US markets and explore the top gainers and losers in today's after-hours session.
Via Chartmill · November 25, 2025
Kartoon Studios Mainframe Studios, Toon Media, and Premium IP Pipeline Drive 2026-2027 Outlook
Kartoon Studios (NYSE: TOON) announced significant momentum across its global content ecosystem as Mainframe Studios, Toon Media Networks, and its high-profile IP pipeline continue to fuel long-term growth.
Via AB Newswire · November 24, 2025
Top movers in Monday's sessionchartmill.com
Intrigued by the market activity in the middle of the day on Monday? Uncover the key winners and losers of today's session in our insightful analysis.
Via Chartmill · November 24, 2025
The market is filled with gapping stocks in Monday's session.chartmill.com
In today's session, there are notable price gaps in the US markets on Monday. Take a closer look at the stocks that are gap up and gap down.
Via Chartmill · November 24, 2025
Gelteq Announces Positive Preclinical Results Demonstrating Enhanced Bioavailability Using Its Proprietary Gel-Based Drug Delivery Platformstocktwits.com
Findings Anticipated to Unlock Broad New Commercial Opportunities Across Water-Soluble Drug Classes
Via Stocktwits · November 24, 2025
12 Health Care Stocks Moving In Friday's After-Market Sessionbenzinga.com
Via Benzinga · October 10, 2025
12 Health Care Stocks Moving In Monday's Pre-Market Sessionbenzinga.com
Via Benzinga · September 8, 2025
Top movers analysis one hour before the close of the markets on 2025-09-05: top gainers and losers in today's session.chartmill.com
Let's have a look at what is happening on the US markets one hour before the close of the markets on Friday. Below you can find the top gainers and losers in today's session.
Via Chartmill · September 5, 2025
12 Health Care Stocks Moving In Friday's Intraday Sessionbenzinga.com
Via Benzinga · September 5, 2025
Friday's session: top gainers and loserschartmill.com
Curious to know what's happening on the US markets in the middle of the day on Friday? Join us as we explore the top gainers and losers in today's session.
Via Chartmill · September 5, 2025